Showing results (401-410 of 442) with videos related to
Sort By:
Pageof 45
European Journal of Human Genetics : EJHG|February 5, 1998
Mitochondrial sequence variants in patients with schizophreniaE Lindholm, L Cavelier, W M Howell, et al.Thrombosis Research|May 4, 2010
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trialsR J Friedman, O E Dahl, N Rosencher, et al.Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Orthopedic surgery modulates neuropeptides and BDNF expression at the spinal and hippocampal levelsMing-Dong Zhang, Swapnali Barde, Ting Yang, et al.Thrombosis Research|May 20, 2008
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.Acta Anaesthesiologica Scandinavica|September 6, 2020
Characteristics and outcomes of patients with COVID-19 admitted to ICU in a tertiary hospital in Stockholm, SwedenEmma Larsson, Olof Brattström, Christina Agvald-Öhman, et al.Journal of Thrombosis and Haemostasis : JTH|December 17, 2003
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyB I Eriksson, G Agnelli, A T Cohen, et al.The New England Journal of Medicine|June 27, 2008
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplastyBengt I Eriksson, Lars C Borris, Richard J Friedman, et al.Frontiers in Immunology|July 25, 2022
The Neuroimmune Response to Surgery - An Exploratory Study of Trauma-Induced Changes in Innate Immunity and Heart Rate VariabilityMalin Hildenborg, Jessica Kåhlin, Fredrik Granath, et al.Lancet (London, England)|September 18, 2007
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trialBengt I Eriksson, Ola E Dahl, Nadia Rosencher, et al.Journal of Thrombosis and Haemostasis : JTH|September 4, 2007
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trialB I Eriksson, O E Dahl, N Rosencher, et al.Pageof 45